CRYOSITE LIMITED (CTE) operates in the Pharmaceuticals Biotechnology & Life Sciences industry category. Cryosite Limited engages in the provision of supply chain logistics services; and management of pharmaceutical products used in clinical trials, and management of biological materials in Australia
The most recent ex-dividend date was 14-03-2017. This dividend was $0.005 and was not franked. and was partially franked at 0%. The date paid for this dividend is 31-03-2017.